Abstract
Because HCV RNA-dependent RNA polymerase is error-prone and the viral RNA has a high turnover rate, the genetic diversity of HCV is very high both in vitro and in vivo. The mutation rate in long-term replicon cultures approaches 3.0 × 10-3 base substitutions/site/year in this in vitro replication model. A direct consequence of the high mutation rate is the rapid emergence of drug-resistant variants, both in cell culture and in patients. Selectable replicons have been used extensively to isolate and characterize drug-resistant HCV genomes in vitro. Typically, replicon cells are plated at a low density and then subjected to a double selection by G418 and escalating dosages of a compound of choice. Here we describe an alternative screening assay that takes advantage of an HCV replicon that is amenable to live-cell sorting with a suitable flow cytometer. We also present a strategy for determining the relative contribution to the resistance by viral genome and host cells. We use selection and characterization of Cyclosporine A (CsA)-resistant replicons as a example to present the protocols, but this method can easily be adapted for the selection of replicon cells resistant to other chemical compounds as long as the compound does not fluoresce at the same wavelength as the fluorescent reporter protein in the replicon.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Blight, K. J., Kolykhalov, A. A., and Rice, C. M. (2000) Efficient initiation of HCV RNA replication in cell culture. Science 290, 1972–1974.
Kato, N., Nakamura, F., Dansako, H., Namba, K., Abe, K., Nozaki, A., et al. (2005) Genetic variation and dynamics of hepatitis C virus replicons in long-term cell culture. J. Gen. Virol. 86,645–656.
Lohmann, V., Korner, F., Koch, J., Herian, U., Theilmann, L., and Bartenschlager, R. (1999) Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 285,110–113.
Kukolj, G., McGibbon, G. A., McKercher, G., Marquis, M., Lefebvre, S., Thauvette, L., et al. (2005) Binding site characterization and resistance to a class of non-nucleoside inhibitors of the hepatitis C virus NS5B polymerase. J. Biol. Chem. 280,39260–39267.
Le Pogam, S., Jiang, W. R, Leveque, V., Rajyaguru, S., Ma, H., Kang, H., et al. (2006) In vitro selected Con1 subgenomic replicons resistant to 2′-C-Methyl-Cytidine or to R1479 show lack of cross resistance. Virology 351,349–359.
Le Pogam, S., Kang, H., Harris, S. F., Leveque, V., Giannetti, A. M., Ali, S., et al. (2006) Selection and characterization of replicon variants dually resistant to thumb- and palm-binding nonnucleoside polymerase inhibitors of the hepatitis C virus. J. Virol. 80, 6146–6154.
Lin, C., Lin, K., Luong, Y. P., Rao, B. G., Wei, Y. Y., Brennan, D. L., et al. (2004) In vitro resistance studies of hepatitis C virus serine protease inhibitors, VX-950 and BILN 2061: structural analysis indicates different resistance mechanisms. J. Biol. Chem. 279,17508–17514.
Lu, L., Pilot-Matias, T. J., Stewart, K. D., Randolph, J. T., Pithawalla, R., He, W., et al. (2004) Mutations conferring resistance to a potent hepatitis C virus serine protease inhibitor in vitro. Antimicrob. Agents Chemother. 48,2260–2266.
Migliaccio, G., Tomassini, J. E., Carroll, S. S., Tomei, L., Altamura, S., Bhat, B., et al. (2003) Characterization of resistance to non-obligate chain-terminating ribonucleoside analogs that inhibit hepatitis C virus replication in vitro. J. Biol. Chem. 278,49164–49170.
Mo, H., Lu, L., Pilot-Matias, T., Pithawalla, R., Mondal, R., Masse, S., et al. (2005) Mutations conferring resistance to a hepatitis C virus (HCV) RNA-dependent RNA polymerase inhibitor alone or in combination with an HCV serine protease inhibitor in vitro. Antimicrob. Agents Chemother. 49, 4305–4314.
Naka, K., Takemoto, K., Abe, K., Dansako, H., Ikeda, M., Shimotohno, K., et al. (2005) Interferon resistance of hepatitis C virus replicon-harbouring cells is caused by functional disruption of type I interferon receptors. J. Gen. Virol. 86, 2787–2792.
Pfeiffer, J. K. and Kirkegaard, K. (2005) Ribavirin resistance in hepatitis C virus replicon-containing cell lines conferred by changes in the cell line or mutations in the replicon RNA. J. Virol. 79, 2346–2355.
Sumpter, R., Jr., Wang, C., Foy, E., Loo, Y. M., and Gale, M., Jr. (2004) Viral evolution and interferon resistance of hepatitis C virus RNA replication in a cell culture model. J. Virol. 78,11591–11604.
Young, K. C., Lindsay, K. L., Lee, K. J., Liu, W. C., He, J. W., Milstein, S. L., et al. (2003) Identification of a ribavirin-resistant NS5B mutation of hepatitis C virus during ribavirin monotherapy. Hepatology 38,869–878.
Zhu, H., Nelson, D. R, Crawford, J. M., and Liu, C. (2005) Defective Jak-Stat activation in hepatoma cells is associated with hepatitis C viral IFN-alpha resistance. J. Interferon Cytokine Res. 25,528–539.
Robida, J. M., Nelson, H. B., Liu, Z., and Tang, H. (2007) Characterization of hepatitis C virus subgenomic replicon resistance to cyclosporine in vitro. J. Virol. 81, 5829–5840.
Moradpour, D., Evans, M. J., Gosert, R., Yuan, Z., Blum, H. E., Goff, S. P., et al. (2004) Insertion of green fluorescent protein into nonstructural protein 5A allows direct visualization of functional hepatitis C virus replication complexes. J. Virol. 78, 7400–7409.
Bourne, N., Pyles, R. B., Yi, M., Veselenak, R. L., Davis, M. M., and Lemon, S. M. (2004) Screening for hepatitis C virus antiviral activity with a cell-based secreted alkaline phosphatase reporter replicon system. Antiviral Res. 67, 76–82.
Nelson, H. B. and Tang, H. (2006) Effect of cell growth on hepatitis C virus (HCV) replication and a mechanism of cell confluence-based inhibition of HCV RNA and protein expression. J. Virol. 80, 1181–1190.
Acknowledgements
We thank Drs. Charles Rice and Takaji Wakita for I/5A-GFP replicon and full-length clone of JFH-1, respectively. Ruth Didier assisted us in flow cytometry, and the molecular cloning core facility helped with subcloning and sequencing of HCV replicon fragment. H.T. is supported by the American Heart Association and the James Esther King Biomedical Research Program.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Humana Press, a part of Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Robotham, J.M., Nelson, H.B., Tang, H. (2009). Selection and Characterization of Drug-Resistant HCV Replicons In Vitro with a Flow Cytometry-Based Assay. In: Tang, H. (eds) Hepatitis C. Methods in Molecular Biology™, vol 510. Humana Press. https://doi.org/10.1007/978-1-59745-394-3_17
Download citation
DOI: https://doi.org/10.1007/978-1-59745-394-3_17
Publisher Name: Humana Press
Print ISBN: 978-1-58829-970-3
Online ISBN: 978-1-59745-394-3
eBook Packages: Springer Protocols